[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340819-105":59,"doc-detail-340819-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","functional-transcriptional-signatures-for-tumor-type-agnostic-phenotype-prediction","Functional transcriptional signatures for tumor-type-agnostic phenotype prediction","","Gene expression-based models can predict tumor traits such as resistance to anticancer therapy, yet transferring these predictors across cancer types and datasets remains difficult. The study introduces a nonnegative matrix factorization framework that decomposes gene expression into a universal set of archetype “fingerprints,” constrained to five defined biological pathways. Six archetypes unify variation across 54 tissue types, 1504 cancer cell lines, and 1770 patient samples, link archetype mixtures to therapy sensitivities, and identify poor prognostic subgroups in breast, colorectal, and pancreatic cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/functional-transcriptional-signatures-for-tumor-type-agnostic-phenotype-prediction/340819/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/functional-transcriptional-signatures-for-tumor-type-agnostic-phenotype-prediction/340819.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are gene-expression predictors hard to generalize across multiple cancers?","Question",{"text":112,"@type":113},"Predictive patterns and treatment responses vary across cancer types and datasets, making it difficult for models learned on one context to transfer reliably to others.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the core method proposed in the study?",{"text":117,"@type":113},"The study uses a nonnegative matrix factorization approach that decomposes gene expression into a universal set of archetype fingerprints, constrained to five well-defined biological pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"How are the resulting archetypes validated and what do they help explain?",{"text":121,"@type":113},"The six archetypes unify gene expression variation across many tissue types, cell lines, and patient samples, correlate with sensitivity to several anticancer therapies, and help explain subtype-specific breast cancer characteristics and poor prognostic subgroups in multiple cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340819,1790451969,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","bioRxiv preprint doi: [https://doi.org/10.1101/2023.04.12.536595](https://doi.org/10.1101/2023.04.12.536595); this version posted April 13, 2023. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \nCancer heterogeneity is defined by normal cellular trade-offs  \nCorey Weistuch, 1 Kevin A. Murgas,2 Jiening Zhu,3 Larry Norton,4  \nKen A. Dill,5 Joseph O. Deasy, 1 and Allen R. Tannenbaum6, 3  \n1 Memorial Sloan Kettering Cancer Center, Department of Medical Physics  \n2 Stony Brook University, Department of Biomedical Informatics  \n3 Stony Brook University, Department of Applied Mathematics and Statistics  \n4 Memorial Sloan Kettering Cancer Center, Department of Medicine  \n5 Stony Brook University, Department of Biomedical Engineering  \n6 Stony Brook University, Department of Computer Science (Dated: April 12, 2023)  \nGene expression predicts tumor characteristics such as resistance to anticancer therapy. However, generalizing these predictors to multiple cancer types and data sets to motivate new therapeutic strategies has proven difficult. Here, we present a nonnegative matrix factorization (NMF) approach that decomposes gene expression into a universal set of “archetype” fingerprints. By restricting our analysis to five well-defined biological pathways, we show that trade-offs between normal tissues constrain oncogenic heterogeneity. Thus, the resulting six archetypes unify gene expression variation across 54 tissue types, 1504 cancer cell lines, and 1770 patient samples. The archetype mixtures correlate with cancer cell line sensitivity to several common anticancer therapies, even among cancers of the same type. They also explain subtype-specific breast cancer characteristics and define poor prognostic subgroups in breast, colorectal, and pancreatic cancers. Overall, the approach offers an evolvable resource for understanding commonalities across cancers, which could eventually lead to more robust therapeutic strategies.  \nINTRODUCTION  \nTumors, even those derived from the same tissue type, can exhibit very different gene expression profilesand treatment responses. However, recent evidence has emerged that these patterns often follow similar rules across different cancers [1–3] . For example, many cancers exhibit subtypes that are relatively enriched for either glycolytic or oxidative metabolism (the “Warburg effect” [4, 5]) . However, three fundamental questions remain unanswered. What do these patterns represent? How do we identify these patterns from molecular data? And how might we exploit them in the clinic?  \nA major aspect of cancer heterogeneity can be understood in terms of trade-offs. Trade-offs are ubiquitous in nature and explain, for example, why the human body requires a diversity of specialized tissues and why cancers adapt to different environmental conditions [5–9] . The Warburg effect exemplifies the concept of an oncogenic trade-off, or a constraint involving the gain of a tumorigenic quality in lieu of another [4, 10] . The Warburg phenotype is observed as an increase in glycolysis in exchange for reduced oxidative phosphorylation, which can promote tumor growth. This effect has been described in breast cancer across molecular subtypes, where basal-like tumors exhibit greater glycolytic metabolism compared to luminal-like breast tumors [1] . Another key oncogenic trade-off includes the migration/proliferation dichotomy, where typically proliferative cancer cells can adapt to a low-proliferation and high-motility state in response to hypoxia, which then may support the development of invasive metastatic disease [11] .  \nRecently developed mathematical tools have enabled trade-offs to be identified in high-dimensional settings, such as cancer gene expression data. Here, the data are modeled as mixtures of a set of fully-s","cbCaibqpffGxUHCq","https://ap.wps.com/l/cbCaibqpffGxUHCq","pdf",866104,15,"English","# Introduction\n## Cancer heterogeneity and trade-offs\n## Archetypal analysis and NMF approach","[{\"question\":\"Why are gene-expression predictors hard to generalize across multiple cancers?\",\"answer\":\"Predictive patterns and treatment responses vary across cancer types and datasets, making it difficult for models learned on one context to transfer reliably to others.\"},{\"question\":\"What is the core method proposed in the study?\",\"answer\":\"The study uses a nonnegative matrix factorization approach that decomposes gene expression into a universal set of archetype fingerprints, constrained to five well-defined biological pathways.\"},{\"question\":\"How are the resulting archetypes validated and what do they help explain?\",\"answer\":\"The six archetypes unify gene expression variation across many tissue types, cell lines, and patient samples, correlate with sensitivity to several anticancer therapies, and help explain subtype-specific breast cancer characteristics and poor prognostic subgroups in multiple cancers.\"}]","Functional transcriptional signatures for tumor-type-agnostic phenotype prediction | PDF",1790039039,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9508ec6142889090f2ecd6553bf0ec59.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4a4ca0ae11a5c86d88675b768e11db3.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a489aeec9aad64da707224fdc700ed83.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9b317dc5b0f9f5af970c4867f967934.webp",980,1268]